Abdul, Moried R.

HRN: 23-43-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/14/2025
12/21/2025
IV
425MG
Q6
URTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: